" another product we could actually lose money on " . Until company reports net profit think we're unlikely to see decent share improvement . Company obviously makes good money but at the end of the day its all about how much what we're left with , net profit . With our track record of net loses and buying costly products/ leases which have yet to prove their worth not hard to see why share value pretty much going nowhere but side way's . Until there's real evidence our costly products/ leases likely to pay off even if they do within a reasonable time frame , company needs to keep generating enough income to be able to afford carrying these products that hopefully makes money for us eventually . Hard to see net profit anytime soon ( hope I'm wrong) just hoping company reports impressive turnover and an acceptable level of debt + net profit expected not too far away .
- Forums
- ASX - By Stock
- MYX
- Ann: FDA approval of HALOETTE, a generic version of NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
3.18%
!
$4.87

Ann: FDA approval of HALOETTE, a generic version of NUVARING, page-23
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.87 |
Change
-0.160(3.18%) |
Mkt cap ! $396.4M |
Open | High | Low | Value | Volume |
$5.03 | $5.03 | $4.86 | $950.5K | 193.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3140 | $4.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.89 | 3333 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 429 | 4.870 |
3 | 1301 | 4.860 |
6 | 52647 | 4.850 |
6 | 2536 | 4.840 |
2 | 1068 | 4.830 |
Price($) | Vol. | No. |
---|---|---|
4.880 | 1997 | 13 |
4.890 | 3898 | 9 |
4.900 | 1511 | 4 |
4.910 | 1223 | 4 |
4.920 | 1327 | 4 |
Last trade - 14.07pm 23/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |